Walnut, CA, United States of America

Zufan Wu

This inventor holds 3 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Amgen Inc.. Active years: 2021-2025.

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 10.0

ph-index = 2

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Zufan Wu

Introduction

Zufan Wu is an accomplished inventor based in Walnut, CA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the synthesis of complex compounds. With a total of 3 patents to her name, her work has garnered attention in the scientific community.

Latest Patents

One of her latest patents includes the synthesis of omecamtiv mecarbil. This patent provides a detailed synthesis for omecamtiv mecarbil dihydrochloride hydrate and various intermediates. This innovative approach has the potential to impact the development of treatments for heart conditions.

Career Highlights

Zufan Wu is currently employed at Amgen Inc., a leading biotechnology company. Her role involves research and development, where she applies her expertise in chemistry to create new therapeutic solutions. Her work is instrumental in advancing the company's mission to improve patient outcomes.

Collaborations

Zufan has collaborated with notable colleagues such as Sebastien Caille and Kyle Quasdorf. These partnerships have fostered a dynamic research environment, allowing for the exchange of ideas and expertise.

Conclusion

Zufan Wu's contributions to the field of pharmaceuticals through her innovative patents and collaborative efforts highlight her importance as an inventor. Her work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…